Hudson Bay Capital Management LP Day One Biopharmaceuticals, Inc. Transaction History
Hudson Bay Capital Management LP
- $21.9 Billion
- Q3 2024
A detailed history of Hudson Bay Capital Management LP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 720,108 shares of DAWN stock, worth $9.88 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
720,108
Previous 555,108
29.72%
Holding current value
$9.88 Million
Previous $7.65 Million
31.14%
% of portfolio
0.05%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding DAWN
# of Institutions
178Shares Held
84MCall Options Held
144KPut Options Held
218K-
Ra Capital Management, L.P. Boston, MA7.87MShares$108 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$88.2 Million11.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$80.8 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$66.9 Million1.92% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$62.2 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1.01B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...